Oslo, Norway, October 31, 2023 - Primary insider Michael Engsig, Chief Executive Officer of Nykode Therapeutics ASA, has today acquired 9,850 shares in Nykode Therapeutics ASA at a price of NOK 17.10 per share. 
 
Please see further details in the attached document.